
Home » DIABETES PREVENTION TRIAL ENROLLS FIRST PATIENTS
DIABETES PREVENTION TRIAL ENROLLS FIRST PATIENTS
June 20, 2006
Pennington Management of Clinical Trials (PMCT) has announced that the first patients have been enrolled in a major diabetes-prevention research study. The study is sponsored by a major pharmaceutical company and is a Phase III trial.
Volunteers in California, Texas and Louisiana have signed up to be a part of the placebo-controlled, multicenter clinical study to determine the efficacy and safety of an investigational drug to prevent the onset of Type 2 diabetes in people who are at a high risk of developing the disease.
Potential study participants will reach the tens of thousands throughout the entire qualification-screening period, which ends in October. Trial participants, who are between the ages of 35 to 75, are tested for a condition known as pre-diabetes to see if they qualify. Approximately 2,100 people are expected to participate in the study.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
19Jan
-
21Jan
-
26Jan
-
27Jan
-
27Jan
-
09Feb